Cases & Deals

Boehringer Ingelheim Pharmaceuticals evaluates antibody patents

Clients Boehringer Ingelheim Pharmaceuticals, Inc.

Jones Day represents Boehringer Ingelheim Pharmaceuticals, Inc. in evaluating patents, including antibody-related patents, with respect to validity and infringement, and other issues.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.